Lithium Perchlorate Trihydrate (CAS NO : 13453-78-6)

Lithium perchlorate trihydrate (CAS 13453-78-6) is increasingly recognized as a vital component in the API intermediates market, where its role as a Lewis acid catalyst in Diels-Alder reactions and Baylis-Hillman couplings allows CDMOs to achieve high-precision molecular architectures for complex pharmaceutical synthesis (Pharma/API purity 99% | General Industry purity 98%). Perchloric acid lithium salt trihydrate serves as a high-performance electrolyte precursor for advanced battery technologies, reflecting a significant global sourcing shift toward high purity fine chemicals that ensure anodic stability and superior ionic conductivity in next-generation energy storage systems (Pharma/API purity 99% | General Industry purity 98%). Lithium perchlorate hydrate remains a preferred choice for custom synthesis services requiring stringent regulatory compliance and moisture-controlled environments, particularly as a chaotropic agent for protein denaturation and nucleic acid purification in specialized biopharmaceutical workflows (Pharma/API purity 99% | General Industry purity 98%). We are an globally established Lithium Perchlorate Trihydrate intermediates supplier with >= 99% purity, ensuring minimal carry-over of impurities in the final API, and a broad range of various pharmaceutical intermediates for API manufacturers and finished formulators, providing comprehensive analytical (HPLC/NMR/MS) and supporting Lithium Perchlorate Trihydrate COA/TDS/SDS region-specific regulatory support. reliable lead times, worldwide supply chain capabilities